Playback speed
10 seconds
Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
23 views
November 2, 2018
Dr. Jack West reviews data from ESMO 2017 & the NEJM paper on the PACIFIC ...
read more ↘ trial of durvalumab vs. placebo as consolidation after chemoradiation for patients with unresectable stage III NSCLC, focusing especially on why these results are practice-changing.
↖ read less
read more ↘ trial of durvalumab vs. placebo as consolidation after chemoradiation for patients with unresectable stage III NSCLC, focusing especially on why these results are practice-changing.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung